PharmaCyte Biotech (PMCB) Cash & Current Investments (2012 - 2026)
PharmaCyte Biotech's Cash & Current Investments was $17.84 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 32.7% from $13.44 million a year earlier but down 5.4% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Cash & Current Investments (2012 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Cash & Current Investments at PharmaCyte Biotech came in at $18.86 million, up 21.4% from FY2025.
- Cash & Current Investments shows a five-year compound annual growth rate of 53.6% (FY2021 to FY2026).
- In earlier fiscal years, Cash & Current Investments was $15.54 million in FY2025 (-69.0%), $50.18 million in FY2024 (-26.2%), $68.04 million in FY2023 (-20.3%) and $85.4 million in FY2022.
- Quarterly Cash & Current Investments has moved between $13.44 million (fiscal Q1 2026) and $86.94 million (fiscal Q2 2022) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for three straight quarters, with an average decline of 27.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was fiscal Q1 2027 (growth of 32.7%); the worst was fiscal Q3 2025 (a decline of 72.6%).
- Per Business Quant data, PMCB's Cash & Current Investments in the three fiscal quarters before Q1 2027 was $18.86 million (Q4 2026), $20.54 million (Q3 2026) and $15.61 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | PharmaCyte Biotech | 3.86 Mn | -68.98 Mn | - | 17.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 17.84 Mn |
| Apr 30, 2026 | 18.86 Mn |
| Jan 31, 2026 | 20.54 Mn |
| Oct 31, 2025 | 15.61 Mn |
| Jul 31, 2025 | 13.44 Mn |
| Apr 30, 2025 | 15.54 Mn |
| Jan 31, 2025 | 16.76 Mn |
| Oct 31, 2024 | 20.84 Mn |
| Jul 31, 2024 | 32.64 Mn |
| Apr 30, 2024 | 50.18 Mn |
| Jan 31, 2024 | 61.21 Mn |
| Oct 31, 2023 | 73.43 Mn |
| Jul 31, 2023 | 74.66 Mn |
| Apr 30, 2023 | 68.04 Mn |
| Jan 31, 2023 | 72.64 Mn |
| Oct 31, 2022 | 76.96 Mn |
| Jul 31, 2022 | 82.23 Mn |
| Apr 30, 2022 | 85.40 Mn |
| Jan 31, 2022 | 86.64 Mn |
| Oct 31, 2021 | 86.94 Mn |
API Access
PharmaCyte Biotech Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();